Atrial Fibrillation Clinical Trials in Overland Park, Kansas

6 studies are recruiting for atrial fibrillation in Overland Park, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

   The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).

   Stage

   Not phased

   Ages

   22 and older

   Site

   The Kansas City Heart Rhythm Institute, Overland Park, Kansas

   Locations

   22 in total

   Run by

   Biosense Webster, Inc.

   See if you can join NCT07227532 on ClinicalTrials.gov

2. Tracking Results of Ablations to Combat AF Registry Generation 2

   The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kansas City Heart Rhythm Institute, Overland Park, Kansas

   Locations

   29 in total

   Run by

   AtriCure, Inc.

   See if you can join NCT05111015 on ClinicalTrials.gov

3. Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

   Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.

   Stage

   Not phased

   Ages

   21 and older

   Site

   Kansas City Cardiac Arrhythmia Research LLC, Overland Park, Kansas

   Locations

   4 in total

   Run by

   Volta Medical

   See if you can join NCT06056271 on ClinicalTrials.gov

4. Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure

   This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural gu…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Kansas City Heart Rhythm Institute - Roe Clinic, Overland Park, Kansas

   Run by

   Kansas City Heart Rhythm Research Foundation

   See if you can join NCT06061757 on ClinicalTrials.gov

5. Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

   This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kansas City Heart Rhythm Institute, Overland Park, Kansas

   Run by

   Kansas City Heart Rhythm Research Foundation

   See if you can join NCT06075628 on ClinicalTrials.gov

6. Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

   The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kansas City Heart Rhythm Institute - Roe Clinic, Overland Park, Kansas

   Locations

   6 in total

   Run by

   Kansas City Heart Rhythm Research Foundation

   See if you can join NCT06078735 on ClinicalTrials.gov